• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成和评价色酮衍生物作为单胺氧化酶抑制剂。

Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase.

机构信息

Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom, 2520, South Africa.

Pharmaceutical Chemistry, School of Pharmacy, North-West University, Private Bag X6001, Potchefstroom, 2520, South Africa.

出版信息

Mol Divers. 2019 Nov;23(4):897-913. doi: 10.1007/s11030-019-09917-8. Epub 2019 Jan 21.

DOI:10.1007/s11030-019-09917-8
PMID:30666491
Abstract

Based on reports that chromone compounds are good potency inhibitors of monoamine oxidase (MAO), the present study evaluates the effect of substitution with flexible side chains on the 3 position on MAO inhibition potency. Fifteen chromone derivatives were synthesised by reacting aromatic and aliphatic amines and alcohols with chromone 3-carboxylic acid in the presence of carbonyldiimidazole (CDI). This yielded chromane-2,4-dione and ester chromone derivatives. Generally, the esters exhibited weak MAO inhibition, while the chromane-2,4-dione derivatives showed promise as selective MAO-B inhibitors with IC values in the micromolar range. Compound 14b, 3-[(benzylamino)methylidene]-3,4-dihydro-2H-1-benzopyran-2,4-dione, was the most potent MAO-B inhibitor with an IC value of 638 µM. This compound was shown to be a reversible and competitive MAO-B inhibitor with a K of 94 µM. In conclusion, the effect of chain elongation and introduction of flexible substituents on position 3 of chromone were explored and the results showed that aminomethylidene substitution is preferable over ester substitution. Good potency MAO-B inhibitors may act as leads for the design and development of therapy for Parkinson's disease where these agents reduce the central metabolism of dopamine.

摘要

基于报道称色酮化合物是单胺氧化酶(MAO)的有效抑制剂,本研究评估了在 3 位取代具有柔性侧链对 MAO 抑制活性的影响。通过在羰基二咪唑(CDI)存在下,用芳香族和脂肪族胺和醇与色酮 3-羧酸反应,合成了 15 种色酮衍生物。这得到了色烷-2,4-二酮和酯色酮衍生物。通常,酯类表现出较弱的 MAO 抑制活性,而色烷-2,4-二酮衍生物作为选择性 MAO-B 抑制剂具有希望,其 IC 值在微摩尔范围内。化合物 14b,3-[(苄氨基)亚甲基]-3,4-二氢-2H-1-苯并吡喃-2,4-二酮,是最有效的 MAO-B 抑制剂,IC 值为 638 µM。该化合物被证明是一种可逆和竞争性的 MAO-B 抑制剂,K 值为 94 µM。总之,探索了在色酮的 3 位延长链和引入柔性取代基的效果,结果表明亚氨基取代优于酯取代。具有良好活性的 MAO-B 抑制剂可能成为设计和开发治疗帕金森病的先导化合物,这些药物可减少多巴胺的中枢代谢。

相似文献

1
Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase.合成和评价色酮衍生物作为单胺氧化酶抑制剂。
Mol Divers. 2019 Nov;23(4):897-913. doi: 10.1007/s11030-019-09917-8. Epub 2019 Jan 21.
2
Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.C7 取代色酮衍生物作为单胺氧化酶抑制剂的研究。
Bioorg Chem. 2012 Dec;45:1-11. doi: 10.1016/j.bioorg.2012.08.003. Epub 2012 Aug 31.
3
Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.色原酮,单胺氧化酶抑制剂开发的优势骨架。
J Med Chem. 2011 Jul 28;54(14):5165-73. doi: 10.1021/jm2004267. Epub 2011 Jul 1.
4
Syntheses and Evaluation of 2- or 3-(N-Cyclicamino)chromone Derivatives as Monoamine Oxidase Inhibitors.2-或3-(N-环氨基)色酮衍生物作为单胺氧化酶抑制剂的合成与评价
Chem Pharm Bull (Tokyo). 2020;68(11):1082-1089. doi: 10.1248/cpb.c20-00579.
5
Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.某些 C6-取代色酮衍生物对单胺氧化酶的抑制作用。
Eur J Med Chem. 2012 Mar;49:343-53. doi: 10.1016/j.ejmech.2012.01.037. Epub 2012 Jan 24.
6
Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.作为选择性单胺氧化酶-B抑制剂的合成色酮的结构探索:一篇综述短文
Comb Chem High Throughput Screen. 2017;20(6):522-532. doi: 10.2174/1386207320666170227155517.
7
Selected chromone derivatives as inhibitors of monoamine oxidase.选定的色酮衍生物作为单胺氧化酶抑制剂。
Bioorg Med Chem Lett. 2012 Sep 1;22(17):5480-4. doi: 10.1016/j.bmcl.2012.07.025. Epub 2012 Jul 14.
8
α-Tetralone derivatives as inhibitors of monoamine oxidase.α-四氢萘酮衍生物作为单胺氧化酶抑制剂
Bioorg Med Chem Lett. 2014 Jun 15;24(12):2758-63. doi: 10.1016/j.bmcl.2014.04.021. Epub 2014 Apr 16.
9
Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives.3,4-二氢-2(1H)-喹啉酮衍生物对单胺氧化酶的抑制作用。
Bioorg Med Chem Lett. 2013 Oct 15;23(20):5498-502. doi: 10.1016/j.bmcl.2013.08.071. Epub 2013 Aug 22.
10
Synthesis and biological evaluation of 3-styrylchromone derivatives as selective monoamine oxidase B inhibitors.3-取代苯乙烯基色酮衍生物的合成及生物评价作为选择性单胺氧化酶 B 抑制剂。
Bioorg Med Chem. 2021 Jul 15;42:116255. doi: 10.1016/j.bmc.2021.116255. Epub 2021 Jun 5.

引用本文的文献

1
Inhibition of monoamine oxidases and neuroprotective effects: chalcones vs. chromones.单胺氧化酶的抑制作用与神经保护作用:查耳酮与色酮的比较
Mol Divers. 2025 Jun;29(3):2063-2079. doi: 10.1007/s11030-024-10959-w. Epub 2024 Aug 15.
2
Synthesis of Chroman-2,4-diones via Ring-Opening/Ring-Closing Reaction Involving Palladium-Catalyzed Intramolecular Aryloxycarbonylation.通过涉及钯催化分子内芳氧基羰基化的开环/闭环反应合成苯并二氢吡喃-2,4-二酮
J Org Chem. 2024 Jan 19;89(2):1175-1183. doi: 10.1021/acs.joc.3c02337. Epub 2024 Jan 9.
3
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease.

本文引用的文献

1
Synthesis, characterization, monoamine oxidase inhibition, molecular docking and dynamic simulations of novel 2,1-benzothiazine-2,2-dioxide derivatives.新型 2,1-苯并噻嗪-2,2-二氧化物衍生物的合成、表征、单胺氧化酶抑制、分子对接和动态模拟。
Bioorg Chem. 2018 Oct;80:498-510. doi: 10.1016/j.bioorg.2018.04.012. Epub 2018 Apr 19.
2
Proposing Novel MAO-B Hit Inhibitors Using Multidimensional Molecular Modeling Approaches and Application of Binary QSAR Models for Prediction of Their Therapeutic Activity, Pharmacokinetic and Toxicity Properties.使用多维分子建模方法提出新型 MAO-B 抑制剂及其在二元 QSAR 模型预测其治疗活性、药代动力学和毒性性质中的应用。
ACS Chem Neurosci. 2018 Jul 18;9(7):1768-1782. doi: 10.1021/acschemneuro.8b00095. Epub 2018 May 7.
3
乙酰胆碱酯酶和单胺氧化酶 B 双重抑制剂治疗阿尔茨海默病的最新进展。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2270781. doi: 10.1080/14756366.2023.2270781. Epub 2023 Nov 13.
4
A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023.色酮类作为单胺氧化酶B抑制剂的近期结构探索简评:2017年至2023年的更新
Pharmaceuticals (Basel). 2023 Sep 15;16(9):1310. doi: 10.3390/ph16091310.
5
In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor Agents.基于 4-羟基香豆素的杂环烯胺的计算机模拟和体外研究作为潜在的抗肿瘤剂。
Molecules. 2023 Aug 2;28(15):5828. doi: 10.3390/molecules28155828.
6
Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.色酮作为开发用于神经退行性疾病治疗的小分子的优势骨架的最新进展。
RSC Med Chem. 2022 Jan 31;13(3):258-279. doi: 10.1039/d1md00394a. eCollection 2022 Mar 23.
7
Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling.新型1,3,4-噻二唑化合物作为潜在的单胺氧化酶-A抑制剂——设计、合成、生物学评价及分子模拟
RSC Med Chem. 2020 Aug 18;11(9):1063-1074. doi: 10.1039/d0md00150c. eCollection 2020 Sep 1.
Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.基于哒嗪骨架的新型 3-杂芳基香豆素的合成及构效关系研究作为选择性 MAO-B 抑制剂。
Eur J Med Chem. 2017 Oct 20;139:1-11. doi: 10.1016/j.ejmech.2017.07.045. Epub 2017 Jul 25.
4
Safinamide for the treatment of Parkinson's disease.沙芬酰胺用于治疗帕金森病。
Expert Opin Pharmacother. 2017 Jun;18(9):937-943. doi: 10.1080/14656566.2017.1329819. Epub 2017 May 23.
5
Parkinson disease.帕金森病。
Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13.
6
New Frontiers in Selective Human MAO-B Inhibitors.选择性人单胺氧化酶B抑制剂的新前沿
J Med Chem. 2015 Sep 10;58(17):6717-32. doi: 10.1021/jm501690r. Epub 2015 May 11.
7
Indanones as high-potency reversible inhibitors of monoamine oxidase.茚满酮类作为单胺氧化酶的高效可逆抑制剂。
ChemMedChem. 2015 May;10(5):862-73. doi: 10.1002/cmdc.201500059. Epub 2015 Mar 27.
8
Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry.通过巧妙的化学方法发现两类新型强效单胺氧化酶-B抑制剂。
Chem Commun (Camb). 2015 Feb 18;51(14):2832-5. doi: 10.1039/c4cc08798d.
9
Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).新型单胺氧化酶抑制剂:专利研究综述(2012-2014)。
Expert Opin Ther Pat. 2015 Jan;25(1):91-110. doi: 10.1517/13543776.2014.982535. Epub 2014 Nov 15.
10
Therapy for Parkinson's disease: what is in the pipeline?帕金森病的治疗:正在研发的有哪些?
Neurotherapeutics. 2014 Jan;11(1):24-33. doi: 10.1007/s13311-013-0242-1.